Prevalence of Atrial Fibrillation in the Italian Elderly Population and Projections from 2020 to 2060 for Italy and the European Union: the FAI Project
Overview
Physiology
Authors
Affiliations
Aims: To estimate prevalence of atrial fibrillation (AF) in a representative sample of the Italian elderly population, projecting figures for Italy and the European Union.
Methods And Results: A cross-sectional examination of all subjects aged 65+ years from three general practices in Northern, Central, and Southern Italy started in 2016. Participants were administered a systematic and an opportunistic screening, followed by clinical and electrocardiogram confirmation. The study sample included 6016 subjects. Excluding 235 non-eligible, among the remaining 5781 participation was 78.3%, which left 4528 participants (mean age 74.5 ± 6.8 years, 47.2% men). Prevalence of AF was 7.3% [95% confidence intervals (CI) 6.6-8.1], higher in men and with advancing age (6.6% from systematic plus 0.7% from opportunistic screening). Using prevalence figures, Italian elderly having AF in 2016 were estimated at ∼1 081 000 (95% CI 786 000-1 482 000). Considering stable prevalence, this number will increase by 75% to ∼1 892 000 in 2060 (95% CI 1 378 000-2 579 000). European Union elderly having AF in 2016 were estimated at ∼7 617 000 (95% CI 5 530 000-10 460 000), increasing by 89% to ∼14 401 000 in 2060 (95% CI 10 489 000-19 647 000). In 2016, subjects aged 80+ years represented 53.5% of cases in Italy and 51.2% in the European Union; in 2060, 69.6% and 65.2%, respectively.
Conclusions: Our findings indicate a high burden of AF in coming decades, especially among the oldest-old, who carry the higher AF-related risk of stroke and medical complications.
Cheng C, Lian T, Zhu X, Virdone S, Sun K, Camm J Open Heart. 2025; 12(1).
PMID: 39914996 PMC: 11804197. DOI: 10.1136/openhrt-2024-003109.
Fleury Q, Dubois R, Christophle-Boulard S, Extramiana F, Maison-Blanche P Heart Rhythm O2. 2025; 5(12):862-872.
PMID: 39803625 PMC: 11721725. DOI: 10.1016/j.hroo.2024.09.007.
AIHEMAF-P: An Innovative Healthcare Model for Atrial Fibrillation Patients.
La Regina R, Innelli P, Glisenti F, Bollani G, Leopardi E, Gensini G Pharmacy (Basel). 2024; 12(6).
PMID: 39728852 PMC: 11678834. DOI: 10.3390/pharmacy12060187.
Kristoffersen E, Seiffge D, Meinel T J Neurol. 2024; 272(1):82.
PMID: 39708167 PMC: 11663162. DOI: 10.1007/s00415-024-12832-0.
Dabrowska M, Rzad M, Kanecki K, Lewtak K, Tyszko P, Gorynski P J Clin Med. 2024; 13(21).
PMID: 39518731 PMC: 11546537. DOI: 10.3390/jcm13216592.